Magzter GOLD ile Sınırsız Olun
Sadece 9.000'den fazla dergi, gazete ve Premium hikayeye sınırsız erişim elde edin
PlasmaGen secures ₹150 cr to expand into global markets
Mint Bangalore
|December 23, 2025
Biopharmaceutical company PlasmaGen Biosciences raised ₹150 crore in a new round of equity financing, valuing the firm at more than ₹1,500 crore.
ViNS Bioproducts, a specialty biopharma company, picked up a minority equity stake in PlasmaGen and led the round with participation from existing investors and other pharma companies and family offices.
PlasmaGen will use the new funds to take its business international. The company has identified distribution partners in “key” export markets.
Back home, the company plans to double down on its presence with its current portfolio of plasma-derived therapeutics. The company’s key products include albumin, intravenous immunoglobulin, rabies immunoglobulin, hepatitis B immunoglobulin, and RhD immunoglobulin (anti-D) which it distributes to private hospitals and state hospitals in India.
Bu hikaye Mint Bangalore dergisinin December 23, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Mint Bangalore'den DAHA FAZLA HİKAYE
Mint Bangalore
China's export boom hurts the job prospects of Asia’s Gen-Z
Manufacturing jobs are vanishing as cheap Chinese goods flood in
3 mins
December 19, 2025
Mint Bangalore
RBI clean-up forces rethink on NBFC-fintech co-lending
Co-lending relationships between regulated lenders such as banks and non-banking finance companies (NBFCs) on one side and fintech firms on the other are seen changing significantly in the next three to five years, experts said at a Mint BFSI Summit panel discussion.
2 mins
December 19, 2025
Mint Bangalore
Why IndiGo is Sensex’s worst newcomer
IndiGo's parent, InterGlobe Aviation Ltd, has suffered a sharp selloff due to its operational meltdown days before inclusion in the BSE Sensex.
2 mins
December 19, 2025
Mint Bangalore
All that cheap Chinese stuff is now Europe's problem
Trump's tariffs have redirected the flow of low-valued packages away from the U.S. into backyard warehouses on the Continent; the 'new Silk Road'
8 mins
December 19, 2025
Mint Bangalore
L Catterton bets on Haldiram Snacks
Consumer-focused global investment firm L Catterton has invested an undisclosed amount in Temasek-backed Haldiram Snacks Food Pvt. Ltd and entered into a strategic partnership, as private equity interest in India’s snacks and packaged foods sector continues to rise.
1 min
December 19, 2025
Mint Bangalore
SHANTI bill to open up nuclear sector gets RS nod amid concerns
The Rajya Sabha on Thursday passed the bill to open up nuclear power generation to the private sector and ease liabilities on suppliers amid the Opposition's concerns over allowing private players in the sector and the lack of liabilities for suppliers of components.
1 mins
December 19, 2025
Mint Bangalore
How child-free couples are rethinking retirement math
Focus is on flexibility, experiences and early retirement over traditional child-centric targets
3 mins
December 19, 2025
Mint Bangalore
Nuclear recharge: Let's hedge our import bets
India's new nuclear law aligns our framework with global norms and looks set to revive a languishing source of clean energy. But don't give up on efforts to minimize import reliance
2 mins
December 19, 2025
Mint Bangalore
India's RDI Fund: We just cannot afford to miss our R&D moment
The Centre's big push is in the right direction but outcomes will depend on how well we redesign the broader R&D ecosystem
2 mins
December 19, 2025
Mint Bangalore
Sumitomo Realty bets on Mumbai
Japan’s Sumitomo Realty and Development, the country’s third-largest developer, plans to expand in India with an unusual strategy: focusing on Mumbai and managing apartments rather than selling them, executives told Reuters.
1 min
December 19, 2025
Listen
Translate
Change font size